Patents expiring in 2038

US 9962448

Compounds and methods for targeted immune system delivery

Northwestern University · Granted Tue May 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9963478

Mannose derivatives for treating bacterial infections

Vertex Pharmaceuticals Incorporated · Granted Tue May 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9962352

Creatine oral supplementation using creatine hydrochloride salt

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue May 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9962366

Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof

Amazentis SA · Granted Tue May 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9962377

Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors

TAKEDA GMBH · Granted Tue May 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2018083171

COMPOSÉS SPIRO EN TANT QUE MODULATEURS DE S1P

ABBVIE DEUTSCHLAND [DE] · Granted Fri May 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Thu May 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9969705

Fused heterocyclic compound

Takeda Pharmaceutical Company Limited · Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9968644

Traditional chinese medicine composition for sober-up and hepatic protection and a process for preparing the same

INFINITUS (CHINA) COMPANY LTD. · Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9968586

Mast cell stabilizers treatment for systemic disorders

Patara Pharma, LLC · Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9968612

Method of synthesizing thyroid hormone analogs and polymorphs thereof

Madrigal Pharmaceuticals, Inc. · Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9968598

Process of making stable abuse-deterrent oral formulations

Collegium Pharmaceutical, Inc. · Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9968587

Heterocycle analogs of CAI-1 as agonists of quorum sensing in vibrio

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9968595

Pharmaceutical compositions of therapeutically active compounds

Agios Pharmaceuticals, Inc. · Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9970037

Methods and materials for making simvastatin and related compounds

The Regents of the University of California · Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9968613

Use of a ppar-delta agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb

VTV THERAPEUTICS LLC · Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9970006

Compositions and methods for inhibition of expression of apolipoprotein C-III (APOC3) genes

Alnylam Pharmaceuticals, Inc. · Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9970059

Survival predictor for diffuse large B cell lymphoma

The United States of America, as Represented by the Secretary, Department of Human Services · Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9969998

Compositions of adenosine deaminase-2 (ADA2), variants thereof and methods of using same

HALOZYME, INC. · Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9969975

Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

Precision BioSciences, Inc. · Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9969754

Compounds for treating spinal muscular atrophy

PTC THERAPEUTICS, INC. · Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9969790

Compositions and methods for immunomodulation in an organism

UNIVERSITY OF CONNECTICUT · Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9969777

Mutant spike protein extending the tissue tropism of infectious bronchitis virus (IBV)

The Pirbright Institute · Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9969804

Methods and compositions for treating and preventing disease associated with alpha-V beta-8 integrin

The Regents of the University of California · Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9968641

Method to suppress the systemic toxicity of chemotherapeutic drugs

UNITED ARAB EMIRATES UNIVERSITY · Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9969970

DNA-cell conjugates

The Regents of the University of California · Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9969719

Substituted 2-hydrogen-pyrazole derivative serving as anticancer drug

Medshine Discovery Inc. · Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9968693

Small molecule imaging of fungi by positron emission tomography scanning

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9968642

Compositions and methods for treatment of pain

Northwestern University · Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9968664

Fusion molecule based on novel TAA variant

The Regents of the University of California · Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9968669

Gene optimized hantaan virus M segment DNA vaccine for hemorrhagic fever with renal syndrome

The United States of America as represented by the Secretary of the Army · Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9968674

Methods and compositions comprising a combination of a VEGF Trap and an anti-CTLA-4 antibody

REGENERON PHARMACEUTICALS, INC. · Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9969695

N-substituted imidazole carboxylic ester chiral compound containing an ether side chain, its preparation and application

WEST CHINA HOSPITAL, SICHUAN UNIVERSITY · Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9968631

Method for treatment of pulmonary fibrosis

GALECTIN THERAPEUTICS, INC. · Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9968638

Compositions and methods for transplantation of colon microbiota

Regents of the University of Minnesota · Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9968653

Angiopoietin-based interventions for treating cerebral malaria

REGENERON PHARMACEUTICALS, INC. · Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9969709

Guanidinobenzoic acid ester compound

Takeda Pharmaceutical Company Limited · Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9969742

Imidazotriazinone compounds

IRONWOOD PHARMACEUTICALS, INC. · Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9969803

Monoclonal antibodies that inhibit the Wnt signaling pathway and methods of production and use thereof

The Board of Regents of the University of Oklahoma · Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 3320902

VERFAHREN ZUR BEHANDLUNG VON ERKRANKUNGEN MIT ISOINDOLINVERBINDUNGEN

CELGENE CORP [US] · Granted Wed May 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue May 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 3043000

DERIVES DE PROSTAGLANDINE LIBERANT DE L'OXYDE NITRIQUE POUR LE TRAITEMENT DU GLAUCOME A TENSION NORMALE

BAUSCH & LOMB [US] · Granted Thu May 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed May 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9976123

Cellular seeding and co-culture of a three dimensional fibroblast construct

Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9975867

Synthetic process for preparing 2-furoic acid derivatives

Dermira, Inc. · Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9975937

Heterodimers of IL-15 and IL-15R alpha to increase thymic output and to treat lymphopenia

THE UNITED SSTATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9974781

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated · Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9974785

Aromatic heterocyclic derivatives and pharmaceutical applications thereof

SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9974789

Substituted pyrazolopyrimidines as glucocerebrosidase activators

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9974744

Sustained release formulation of a non-steroidal anti-inflammatory drug

Pacira Pharmaceuticals, Inc. · Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9974793

Emulsion formulations of aprepitant

Heron Therapeutics, Inc. · Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)